The Effect of DNS Therapy on Asymmetry in Children After Surgery of Congenital Heart Disease
Launched by CHARLES UNIVERSITY, CZECH REPUBLIC · Jan 14, 2025
Trial Information
Current as of July 28, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
As part of the diploma thesis, a study will be conducted in patients after cardiac surgery performed at the Motol Hospital within the Children's Cardiology Center. The intervention will be performed in Rehabilitation Clinic Teplice nad Bečvou. The study group will include children aged 6-18 years after VSV surgery without other serious health complications. The subjects will undergo therapy according to DNS for 3 weeks. Therapy according to DNS will take place twice a day (1x individual physiotherapy 40 minutes, 1x group 40 minutes) and will be supplemented with conventional therapy (e.g. s...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • children 6-18 years, surgery of congenital heart disease
- Exclusion Criteria:
- • any other disease
About Charles University, Czech Republic
Charles University, located in the Czech Republic, is a prestigious institution renowned for its commitment to advancing medical research and education. As a clinical trial sponsor, the university leverages its extensive academic expertise and state-of-the-art facilities to conduct innovative research that aims to improve patient outcomes and contribute to the global medical community. With a focus on ethical standards and rigorous scientific methodologies, Charles University collaborates with various stakeholders to explore new therapies and enhance healthcare practices, fostering a culture of excellence in clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Prague, , Czechia
Patients applied
Trial Officials
Marcela Safarova, PhD., PhDr.
Study Director
Rehabilitation and Sports Medicine Clinic
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported